Jinyeong Lim

437 total citations
18 papers, 157 citations indexed

About

Jinyeong Lim is a scholar working on Oncology, Cancer Research and Molecular Biology. According to data from OpenAlex, Jinyeong Lim has authored 18 papers receiving a total of 157 indexed citations (citations by other indexed papers that have themselves been cited), including 8 papers in Oncology, 7 papers in Cancer Research and 5 papers in Molecular Biology. Recurrent topics in Jinyeong Lim's work include Cancer Immunotherapy and Biomarkers (5 papers), Genomics and Rare Diseases (2 papers) and Cancer, Hypoxia, and Metabolism (2 papers). Jinyeong Lim is often cited by papers focused on Cancer Immunotherapy and Biomarkers (5 papers), Genomics and Rare Diseases (2 papers) and Cancer, Hypoxia, and Metabolism (2 papers). Jinyeong Lim collaborates with scholars based in South Korea, United States and Germany. Jinyeong Lim's co-authors include Yoon Jung Park, Anders M. Lindroth, Christoph Plass, Soo-Jung Park, So Young Yoon, Jong Bae Park, Hyun Guy Kang, Annika Baude, Christopher R. Schmidt and Jörg Fellenberg and has published in prestigious journals such as Nature Communications, Scientific Reports and Clinical Cancer Research.

In The Last Decade

Jinyeong Lim

16 papers receiving 157 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Jinyeong Lim South Korea	7	76	46	42	37	21	18	157
Nikola Hájková Czechia	9	79 1.0×	37 0.8×	37 0.9×	69 1.9×	22 1.0×	25	194
Helen Pasternack Germany	6	65 0.9×	47 1.0×	94 2.2×	79 2.1×	29 1.4×	11	193
Ian Y. Luk Australia	9	134 1.8×	48 1.0×	29 0.7×	61 1.6×	35 1.7×	11	214
Victoria Damerell South Africa	7	87 1.1×	30 0.7×	45 1.1×	52 1.4×	9 0.4×	8	161
Galina Tsykunova Norway	8	103 1.4×	19 0.4×	21 0.5×	30 0.8×	13 0.6×	25	200
Sumito Shingaki Japan	4	87 1.1×	33 0.7×	24 0.6×	35 0.9×	8 0.4×	15	134
Laura Hurd United States	4	96 1.3×	44 1.0×	60 1.4×	43 1.2×	7 0.3×	4	151
Hai Jiang China	8	232 3.1×	76 1.7×	39 0.9×	46 1.2×	22 1.0×	18	333
Mohammed Bangash Saudi Arabia	7	101 1.3×	49 1.1×	37 0.9×	33 0.9×	36 1.7×	16	214

Countries citing papers authored by Jinyeong Lim

Since Specialization

Citations

This map shows the geographic impact of Jinyeong Lim's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Jinyeong Lim with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Jinyeong Lim more than expected).

Fields of papers citing papers by Jinyeong Lim

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Jinyeong Lim. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Jinyeong Lim. The network helps show where Jinyeong Lim may publish in the future.

Co-authorship network of co-authors of Jinyeong Lim

This figure shows the co-authorship network connecting the top 25 collaborators of Jinyeong Lim. A scholar is included among the top collaborators of Jinyeong Lim based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Jinyeong Lim. Jinyeong Lim is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

18 of 18 papers shown

Lee, Soon Kyu, Jinyeong Lim, Joo Yeon Jhun, et al.. (2025). Landscape of T-cell exhaustion heterogeneity and HBV integration in virus-related HCC revealed by whole-exome, transcriptome, and single-cell sequencing. JHEP Reports. 7(11). 101518–101518.

Lee, Ji Won, Jinyeong Lim, Sunghwan Shin, et al.. (2024). Germline functional variants contribute to somatic mutation and outcomes in neuroblastoma. Nature Communications. 15(1). 8360–8360. 3 indexed citations

Lim, Jinyeong, Myung Ji Goh, Byeong Geun Song, et al.. (2024). Unraveling the immune-activated tumor microenvironment correlated with clinical response to atezolizumab plus bevacizumab in advanced HCC. JHEP Reports. 7(4). 101304–101304.

Lim, Jinyeong, Sung-Won Shin, Woong‐Yang Park, et al.. (2024). Single-Cell Profiling Reveals Immune-Based Mechanisms Underlying Tumor Radiosensitization by a Novel Mn Porphyrin Clinical Candidate, MnTnBuOE-2-PyP5+ (BMX-001). Antioxidants. 13(4). 477–477. 1 indexed citations

Kim, Se Ik, Je‐Gun Joung, Yoo‐Na Kim, et al.. (2024). Durvalumab with or without tremelimumab plus chemotherapy in HRR non-mutated, platinum-resistant ovarian cancer (KGOG 3045): A phase II umbrella trial. Gynecologic Oncology. 182. 7–14. 4 indexed citations

Lim, Jinyeong, In‐Ho Seo, Jae Hwan Jee, et al.. (2024). Single-cell analysis of human PBMCs in healthy and type 2 diabetes populations: dysregulated immune networks in type 2 diabetes unveiled through single-cell profiling. Frontiers in Endocrinology. 15. 1397661–1397661. 6 indexed citations

Kim, Yoo‐Na, Je‐Gun Joung, Eunhyang Park, et al.. (2023). Randomized, two‐arm, noncomparative phase 2 study of olaparib plus cediranib or durvalumab in HRR‐mutated, platinum‐resistant ovarian cancer: A substudy of KGOG 3045. International Journal of Cancer. 153(12). 2032–2044. 6 indexed citations

Jung, Hyun Ae, Keon Uk Park, Sang‐Hee Cho, et al.. (2022). A Phase II Study of Nivolumab plus Gemcitabine in Patients with Recurrent or Metastatic Nasopharyngeal Carcinoma (KCSG HN17–11). Clinical Cancer Research. 28(19). 4240–4247. 18 indexed citations

Kang, JiHoon, Ji‐Young Lee, Sunmin Lee, et al.. (2022). Establishing Patient-Derived Cancer Cell Cultures and Xenografts in Biliary Tract Cancer. Cancer Research and Treatment. 55(1). 219–230. 3 indexed citations

10.

Kim, Eun Na, Ji‐Young Lee, Ji Hun Kim, et al.. (2021). Characterization of early postzygotic somatic mutations through multi-organ analysis. Journal of Human Genetics. 66(8). 777–784. 2 indexed citations

11.

Choi, Yun Mi, Jinyeong Lim, Min Ji Jeon, et al.. (2021). Mutation Profile of Aggressive Pheochromocytoma and Paraganglioma with Comparison of TCGA Data. Cancers. 13(10). 2389–2389. 8 indexed citations

12.

Koh, Kyung‐Nam, Ji‐Young Lee, Jinyeong Lim, et al.. (2020). Genetic Alterations Detected by Targeted Next-generation Sequencing and Their Clinical Implications in Neuroblastoma. Anticancer Research. 40(12). 7057–7065. 4 indexed citations

13.

Lim, Jinyeong, et al.. (2020). EHMT2 Inhibition Induces Cell Death in Human Non-Small Cell Lung Cancer by Altering the Cholesterol Biosynthesis Pathway. International Journal of Molecular Sciences. 21(3). 1002–1002. 24 indexed citations

14.

Lim, Jinyeong, et al.. (2019). Promotion of Cell Death in Cisplatin-Resistant Ovarian Cancer Cells through KDM1B-DCLRE1B Modulation. International Journal of Molecular Sciences. 20(10). 2443–2443. 17 indexed citations

15.

Lim, Jinyeong, Annika Baude, Jörg Fellenberg, et al.. (2018). Transcriptome and protein interaction profiling in cancer cells with mutations in histone H3.3. Scientific Data. 5(1). 180283–180283. 3 indexed citations

16.

Lim, Jinyeong, Annika Baude, Christopher R. Schmidt, et al.. (2017). The histone variant H3.3 G34W substitution in giant cell tumor of the bone link chromatin and RNA processing. Scientific Reports. 7(1). 13459–13459. 39 indexed citations

17.

Pandzic, Tatjana, Verónica Rendo, Jinyeong Lim, et al.. (2017). Somatic PRDM2 c.4467delA mutations in colorectal cancers control histone methylation and tumor growth. Oncotarget. 8(58). 98646–98659. 14 indexed citations

18.

Graham, James E., Stephanie Earnshaw, Jinyeong Lim, Rajyalakshmi Luthra, & Rohit Borker. (2016). Cost-effectiveness of Afatinib versus Erlotinib in the First-line Treatment of Patients with Metastatic Non-small Cell Lung Cancer with EGFR Exon 19 Deletion Mutations. 5 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact